Q3UFT3
Gene name |
Garem1 (Fam59a, Garem, Gm944, Kiaa4238) |
Protein name |
GRB2-associated and regulator of MAPK protein |
Names |
GRB2-associated and regulator of MAPK1 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:381126 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q3UFT3
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q3UFT3-F1 | Predicted | AlphaFoldDB |
60 variants for Q3UFT3
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3408131549 | 12 | K>E | No | EVA | |
| rs3408477203 | 12 | K>M | No | EVA | |
| rs3408477195 | 29 | T>I | No | EVA | |
| rs3408311844 | 30 | Y>* | No | EVA | |
| rs3406439647 | 31 | R>* | No | EVA | |
| rs3389483686 | 63 | T>S | No | EVA | |
| rs3389456922 | 74 | Y>F | No | EVA | |
| rs3389436959 | 152 | D>E | No | EVA | |
| rs3389498164 | 186 | S>F | No | EVA | |
| rs3389469647 | 192 | K>* | No | EVA | |
| rs254747371 | 216 | K>R | No | EVA | |
| rs3408130489 | 224 | P>S | No | EVA | |
| rs47927011 | 225 | L>M | No | EVA | |
| rs3408353089 | 226 | E>G | No | EVA | |
| rs3389498198 | 232 | G>W | No | EVA | |
| rs3389401145 | 245 | L>F | No | EVA | |
| rs3389498118 | 260 | Y>C | No | EVA | |
| rs3389489289 | 271 | Y>C | No | EVA | |
| rs3389469669 | 290 | N>K | No | EVA | |
| rs3406437220 | 316 | D>G | No | EVA | |
| rs3389483099 | 316 | D>N | No | EVA | |
| rs3408242858 | 317 | M>L | No | EVA | |
| rs3408664251 | 318 | W>G | No | EVA | |
| rs3408130503 | 319 | P>T | No | EVA | |
| rs3389490910 | 330 | C>G | No | EVA | |
| rs3389436968 | 359 | K>R | No | EVA | |
| rs1135341283 | 361 | R>C | No | EVA | |
| rs1135341283 | 361 | R>S | No | EVA | |
| rs3389498186 | 362 | C>S | No | EVA | |
| rs3389483644 | 367 | H>L | No | EVA | |
| rs3389436995 | 382 | S>T | No | EVA | |
| rs1132661584 | 385 | R>L | No | EVA | |
| rs3389505937 | 402 | N>I | No | EVA | |
| rs1133982948 | 404 | H>Q | No | EVA | |
| rs3389490866 | 407 | R>G | No | EVA | |
| rs3389493753 | 423 | Y>H | No | EVA | |
| rs3389500989 | 440 | E>K | No | EVA | |
| rs3408382021 | 457 | W>R | No | EVA | |
| rs264498598 | 465 | R>H | No | EVA | |
| rs3389500910 | 476 | S>C | No | EVA | |
| rs3389483079 | 480 | T>S | No | EVA | |
| rs3389493760 | 496 | T>A | No | EVA | |
| rs228443942 | 510 | A>T | No | EVA | |
| rs3389456931 | 517 | P>S | No | EVA | |
| rs1133792286 | 528 | R>Q | No | EVA | |
| rs3389500971 | 562 | R>G | No | EVA | |
| rs3408353116 | 581 | Q>L | No | EVA | |
| rs3389483035 | 594 | C>R | No | EVA | |
| rs3389490412 | 598 | T>I | No | EVA | |
| rs1132523440 | 664 | C>S | No | EVA | |
| rs3389505953 | 678 | S>N | No | EVA | |
| rs3389446992 | 706 | S>F | No | EVA | |
| rs240148961 | 713 | A>T | No | EVA | |
| rs3389483040 | 746 | L>Q | No | EVA | |
| rs3408353125 | 787 | L>P | No | EVA | |
| rs50106372 | 829 | V>F | No | EVA | |
| rs50106372 | 829 | V>I | No | EVA | |
| rs3389490871 | 870 | N>Y | No | EVA | |
| rs864279974 | 875 | K>E | No | EVA | |
| rs864284247 | 875 | K>R | No | EVA |
No associated diseases with Q3UFT3
1 regional properties for Q3UFT3
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | CABIT domain | 32 - 312 | IPR025946 |
No GO annotations of cellular component
| Name | Definition |
|---|---|
| No GO annotations for cellular component |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| proline-rich region binding | Binding to a proline-rich region, i.e. a region that contains a high proportion of proline residues, in a protein. |
5 GO annotations of biological process
| Name | Definition |
|---|---|
| cellular response to epidermal growth factor stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epidermal growth factor stimulus. |
| epidermal growth factor receptor signaling pathway | The series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
| positive regulation of cell division | Any process that activates or increases the frequency, rate or extent of cell division. |
| positive regulation of cell population proliferation | Any process that activates or increases the rate or extent of cell proliferation. |
| positive regulation of ERK1 and ERK2 cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MDPAPSLGCS | LKDVKWSPVA | MPLDLLVSTY | RLPQIARLDS | GECVEGLREN | DFLLIHSCRQ |
| 70 | 80 | 90 | 100 | 110 | 120 |
| WTTITAHSLE | EGHYVIGPKI | EIPVHYAGQF | KLLEQDRDIK | EPVQYFNSVE | EVAKAFPERV |
| 130 | 140 | 150 | 160 | 170 | 180 |
| YVMEEITFNV | KVASGECNED | TEVYNITLCT | GDELTLMGQA | EILYAKTFKE | KSRLNTIFKK |
| 190 | 200 | 210 | 220 | 230 | 240 |
| IGKLNSISKL | GKGKMPCLIC | MNHRTNESIS | LPFQCKGRFS | TRSPLELQMQ | EGEHTIRNIV |
| 250 | 260 | 270 | 280 | 290 | 300 |
| EKTRLPVNVT | VPSPPPRNPY | DLHFIREGHR | YKFVNIQTKT | VVVCCVLRNN | KILPMHFPLH |
| 310 | 320 | 330 | 340 | 350 | 360 |
| LTVPKFSLPE | HQVKGDMWPE | TLVHHWLGIC | QEQFDIDEYS | RAVRDVKTDW | NEDCKSPKKG |
| 370 | 380 | 390 | 400 | 410 | 420 |
| RCSGHNHLPN | SLSYARDELT | QSFHRLSVCV | YGNNLHGNSE | VNLHGCRDLG | GEWAPFPHDI |
| 430 | 440 | 450 | 460 | 470 | 480 |
| LPYQDSGDSG | SDYLFPEANE | ESAGIPGKTE | VPYEELWLEE | GKPSRQPLTR | SLSEKSRCDT |
| 490 | 500 | 510 | 520 | 530 | 540 |
| LRGSTRSTCA | PSSPPTPATL | GATIKSSEIA | LPPPPVPPKS | EAVREECRLL | NAPPVPPRSA |
| 550 | 560 | 570 | 580 | 590 | 600 |
| KPLSTSPSIP | PRTVKPVRPQ | TRSPSPTLSY | YSSGLHNIIT | QSDTSPPNSA | PVSCYPCTRV |
| 610 | 620 | 630 | 640 | 650 | 660 |
| KSDSVDPKSP | FGSPSAEALS | SRLSWPNHYS | GASENQTRSD | FLLDPSRSYS | YPRQKTPGTP |
| 670 | 680 | 690 | 700 | 710 | 720 |
| KRTCPAPFDF | EGCELLGSPP | STTSAEFSSS | GVPSCPKSAS | YCLENSEDNS | FAAGMTKQSV |
| 730 | 740 | 750 | 760 | 770 | 780 |
| SCPALPPRAP | KPVEQKATPE | TSPLPLKIDG | AEEDPTAGSL | DLSEDQYFVR | KGMQDIFSVS |
| 790 | 800 | 810 | 820 | 830 | 840 |
| YPFSSPLHLQ | LAPRSCGDGS | PWQPPADLSG | LSIEEVSKSL | RFIGLSEDVI | AFFVTEKIDG |
| 850 | 860 | 870 | |||
| NLLVQLTEEI | LSEDFKLSKL | QVKKILQFIN | GWRPKI |